Abstract
Diabetes mellitus is the phenotypic expression of a disorder resulting from various environmental factors interacting with a genetic component. It is an heterogeneous metabolic syndrome consisting of a dysregulation of glucose homeostasis, with additional abnormalities in lipid and protein metabolism. This disorder induces both acute and long-term complications, particularly cardiovascular, with an increased rate of morbidity and mortality as compared to the general population. The incidence and associated complications of the disease are in continuous progression; indeed, by the year 2010, the total number of people with diabetes is projected to reach 221 million, as compared to an estimated 124 million in 1997 (Amos et al. 1997). The prevalence of diabetes in adults worldwide was estimated to be 4.0% in 1995 and to rise to 5.4% by the year 2025 (King et al. 1998).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aguilar-Bryan L, Clement IV JP, Gonzalez G, Kunjilwar K, Babenko A, Bryan J (1998) Toward understanding the assembly and structure of KATP channels. Physiol Rev 78:227–245
Amos AF, McCarty DJ, Zimmet P (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Med 14 (Suppl 5):S1–85
Angello DA, Berne RM, Coddington NM (1993) Adenosine and insulin mediate glucose uptake in normoxic rat hearts by different mechanisms. Am J Physiol 265:H880–H885
Arkhammar P, Hallberg A, Kindmark H, Nilsson T, Rorsman P, Berggren PO (1990) Extracellular ATP increases cytoplasmic free Ca2+ concentration in clonal insulin-producing RINm5F cells. Biochem J 265:203–211
Atkinson DE (1978) Cellular energy metabolism and its regulation. Academic Press, San Diego
Baron AD, Brechtel G, Wallace P, Edelman SV (1988) Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol 255:E769–E774
Bertrand G, Chapal J, Loubatières-Mariani MM, Roye M (1987) Evidence for two different P2-purinoceptors on β cell and pancreatic vascular bed. Br J Pharmacol 91:783–787
Bertrand G, Chapal J, Puech R, Loubatières-Mariani MM (1991) Adenosine-5′-O-(2-thiodiphosphate) is a potent agonist at P2 purinoceptors mediating insulin secretion from perfused rat pancreas. Br J Pharmacol 102:627–630
Bertrand G, Nenquin M, Henquin JC (1989a) Comparison of the inhibition of insulin release by activation of adenosine and α 2 -adrenergic receptors in rat β cells. Biochem J 259:223–228
Bertrand G, Petit P, Bozem M, Henquin JC (1989b) Membrane and intracellular effects of adenosine in mouse pancreatic β cells. Am J Physiol 257:E473–E478
Blachier F, Malaisse WJ (1988) Effect of exogenous ATP upon inositol phosphate production, cationic fluxes and insulin release in pancreatic islet cells. Biochem Biophys Acta 970:222–229
Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3–10
Budohoski L, Challis RAJ, McManus B, Newsholme EA (1984) Effects of analogues of adenosine and methyl xanthines on insulin sensitivity in soleus muscle of the rat. FEBS Lett 167:1–4
Campbell IL, Taylor KW (1982). Effects of adenosine, 2-deoxyadenosine and N6-phenylisopropyladenosine on rat islet function and metabolism. Biochem J 204:689–696
Candela JLR, Garcia-Fernandez MC (1963) Stimulation of secretion of insulin by adenosine-triphosphate. Nature 197:1210 (Abstract)
Challis RAJ, Budohoski L, McManus B, Newsholme EA (1984) Effects of an adenosine-receptor antagonist on insulin-resistance in soleus muscle from obese Zucker rats. Biochem J 221:915–917
Challis RAJ, Richards SJ, Budohoski L (1992) Characterization of the adenosine receptor modulating insulin action in rat skeletal muscle. Eur J Pharmacol 226:121–128
Chapal J, Hillaire-Buys D, Bertrand G, Pujalte D, Petit P, Loubatières-Mariani MM (1997) Comparative effects of adenosine 5′-triphosphate and related analogues on insulin secretion from the rat pancreas. Fundam Clin Pharmacol 11:537–545
Chapal J, Loubatières-Mariani MM (1981a) Effects of phosphate-modified adenine nucleotide analogues on insulin secretion from perfused rat pancreas. Br J Pharmacol 73:105–110
Chapal J, Loubatières-Mariani MM (1981b) Attempt to antagonize the stimulatory effect of ATP on insulin secretion. Eur J Pharmacol 74:127–134
Chen YD, Golay A, Swislocki AL, Reaven GM (1987) Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 64:17–21
Cox BF, Clark KL, Perrone MH, Welzel GE, Greenland BD, Colussi DJ, Merkel LA (1997) Cardiovascular and metabolic effects of adenosine Al-receptor agonists in streptozotocin-treated rats. J Cardiovasc Pharmacol 29:417–426
Crist GH, Xu B, Lanoue KF, Lang CH (1998) Tissue-specific effects of in vivo adenosine receptor blockade on glucose uptake in Zucker rats. FASEB J 12:1301–1308
Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986
Dixon AK, Gubitz AK, Sirinathsinghui DJ, Richardson PJ, Freeman TC (1996) Tissue distribution of adenosine receptors mRNAs in the rat. Br J Pharmacol 118: 1461–1468
Ebert R, Schwabe U (1973) Studies on the antilipolytic effect of adenosine and related compounds in isolated fat cells. Naunyn-Schmiedeberg’s Arch Pharmacol 278:247–259
Espinal J, Challiss RAJ, Newsholme EA (1983) Effect of adenosine deaminase and adenosine analogue on insulin sensitivity in soleus muscle of the rat. FEBS Lett 158:103–106
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report. Diabetes Care 20:1183–1197
Fernandez-Alvarez J, Hillaire-Buys D, Manteghetti M, Chapal J, Loubatières-Mariani MM, Gomis R, Petit P (1998) Comparative effects of P2 receptor agonists on insulin secretion from human and rat pancreatic islets. Drug Develop Res 43:62, A 239
Fischer B, Shulkin A, Sheihet L, Boyer JL, Harden KT, Gendron FP, Baudoin AR, Chapal J, Hillaire-Buys D, Petit P (1998) Adenosine 5′-phosphorothioates-2-thioether and 5′-boranophosphate-2-thioether derivatives as potential antidiabetic drugs. Drug Develop Res 43:28, A108
Geschwind JF, Hiriart M, Glennon MC, Najafi H, Corkey BE, Matschinsky FM, Prentki M (1989) Selective activation of Ca2+ influx by extracellular ATP in a pancreatic β-cell line (HIT). Bioch Biophys Acta 1012:107–115
Green A, Johnson JL (1991) Evidence for impaired coupling of receptors to Gi protein in adipocytes from streptozotocin-induced diabetic rats. Diabetes 40:88–94
Gylfe E, Hellman B (1987) External ATP mimics carbachol in initiating calcium mobilization from pancreatic β cells conditioned by previous exposure to glucose. Br J Pharmacol 92:281–289
Han DH, Hansen PA, Nolte LA, Holloszy JO (1998) Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions. Diabetes 47:1671–1675
Hillaire-Buys D, Bertrand G, Chapal J, Puech R, Ribes G, Loubatières-Mariani MM (1993) Stimulation of insulin secretion and improvement of glucose tolerance in rat and dog by the P2Y purinoceptor agonist, adenosine-5′-O-(2-thiodiphosphate). Br J Pharmacol 109:183–187
Hillaire-Buys D, Bertrand G, Gross R, Loubatières-Mariani MM (1987) Evidence for an inhibitory A1 subtype adenosine receptor on pancreatic insulin-secreting cells. Eur J Pharmacol 136:109–112
Hillaire-Buys D, Chapal J, Linck N, Blayac JP, Petit P, Loubatières-Mariani MM (1998) Involvement of K+ channel permeability changes in the L-NAME and indomethacin resistant part of adenosine-5′-O-(2-thiodiphosphate)-induced relaxation of pancreatic vascular bed. Br J Pharmacol 124:149–156
Hillaire-Buys D, Chapal J, Petit P, Loubatières-Mariani MM (1991) Dual regulation of pancreatic vascular tone by P2X and P2Y purinoceptor subtypes. Eur J Pharmacol 199:309–314
Hillaire-Buys D, Gross R, Chapal J, Ribes G, Loubatières-Mariani MM (1992) P2Y purinoceptor responses of β cells and vascular bed are preserved in diabetic rat pancreas. Br J Pharmacol 106:610–615
Hillaire-Buys D, Gross R, Loubatières-Mariani MM, Ribes G (1989) Effect of pertussis toxin on A1 receptor-mediated inhibition of insulin secretion. Br J Pharmacol 96:3–4
Ishikawa J, Mitani H, Bandoh T, Kimura M, Totsuka T, Hayashi S (1998) Hypoglycemic and hypotensive effects of 6-cyclohexyl-2′-O-methyl-adenosine, an adenosine Al receptor agonist, in spontaneously hypertensive rat complicated with hyperglycemia. Diabetes Res Clin Pract 39:3–9
Joost HG, Steinfelder HJ (1982) Modulation of insulin sensitivity by adenosine. Effects on glucose transport, lipid synthesis, and insulin receptors of the adipocyte. Mol Pharmacol 22:614–618
Julius S, Gudbrandsson T, Jamerson K, Shahab ST, Andersson O (1991) The hemodynamic link between insulin resistance and hypertension. J Hypertens 9:983–986
Karoon P, Rubino A, Burnstock G (1995) Enhanced sympathetic neurotransmission in the tail artery of l,3-dipropyl-8 sulphophenylxanthine (DPSPX)-treated rats. Br J Pharmacol 116:1918–1922
Kather H, Bieger W, Michel G, Aktories K, Jakobs KH (1985) Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms. J Clin Invest 76:1559–1565
Kindmark H, Köhler M, Nilsson T, Arkhammar P, Wiechel KL, Rorsman P, Efendic S, Berggren PO (1991) Measurements of cytoplasmic free Ca2+ concentration in human pancreatic islets and insulinoma cells. FEBS Lett 291:310–314
King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431
Kuroda M, Honnor RC, Cushman SW, Londos C, Simpson IA (1987) Regulation of insulin-stimulated glucose transport in the isolated rat adipocyte. J Biol Chem 262:245–253
Law WR, McLane MP, Raymond RM (1988) Adenosine is required for myocardial insulin responsiveness in vivo. Diabetes 37:842–845 Law WR, Raymond RM (1988) Adenosine potentiates insulin-stimulated myocardial glucose uptake in vivo. Am J Physiol 254:H970–H975
Leighton B, Lozeman FJ, Vlachonikolis IG, Challis RAJ, Pitcher JA, Newsholme EA (1988) Effects of adenosine deaminase on the sensitivity of glucose transport, glycolysis and glycogen synthesis to insulin in muscles of the rat. Int J Biochem 20:23–27
Levine RA, Oyama S, Kagan A, Glick SM (1970) Stimulation of insulin and growth hormone secretion by adenine nucleotides in primates. J Lab Clin Med 75:30–36
Li G, Milani D, Dunne MJ, Pralong WF, Théier JM, Petersen OH, Wollheim CB (1991) Extracellular ATP causes Ca2+-dependent and -independent insulin secretion in RINm5F cells. J Biol Chem 266:3449–3457
Londos C, Cooper DMF, Wolff J (1980) Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 77:2551–2554
Loubatières-Mariani MM, Chapal J, Lignon F, Valette G (1979) Structural specificity of nucleotides for insulin secretory action from the isolated perfused rat pancreas. Eur J Pharmacol 59:277–286
Loubatières-Mariani MM, Hillaire-Buys D, Chapal J, Bertrand G, Petit P (1997) P2 purinoceptor agonists: new insulin secretagogues potentially useful in the treatment of non-insulin-dependent diabetes mellitus. In: Jacobson KA, Jarvis MF (eds) Purinergic approaches in experimental therapeutics. Wiley-Liss, pp 253–260
Loubatières-Mariani MM, Petit P, Chapal J, Hillaire-Buys D, Bertrand G, Ribes G (1995) Effects of purinoceptor agonists on insulin secretion. In: Belardinelli L, Pelleg A (eds) Adenosine and adenine nucleotides: From molecular biology to integrative physiology. Kluwer, Boston, pp 337–345
Merkel LA, Hawkins ED, Colussi DJ, Greenland BD, Smits GJ, Perrone MH, Cox BF (1995) Cardiovascular and antilipolytic effects of the adenosine agonist GR79236. Pharmacology 51:224–236
Nomura H, Nagashima K, Kusaka H, Karasawa A (1995) Antihypertensive effects of KW-3902, an adenosine Al-receptor antagonist, in Dahl salt-sensitive rats. Jpn J Pharmacol 68:389–396
Petit P, Bertrand G, Schmeer W, Henquin JC (1989) Effects of extracellular nucleotides on the electrical, ionic and secretory events in mouse pancreatic β cells. Br J Pharmacol 98:875–882
Petit P, Hillaire-Buys D, Manteghetti M, Debrus S, Chapal J, Loubatières-Mariani MM (1998) Evidence for two different types of P2-receptors stimulating insulin secretion from pancreatic B cell. Br J Pharmacol 125:1368–1374
Petit P, Loubatières-Mariani MM, Keppens S, Sheehan MJ (1996) Purinergic receptors and metabolic function. Drug Develop Res 39:413–425
Petit P, Manteghetti M, Loubatières-Mariani MM (1988) Differential effects of purinergic and cholinergic activation on the hydrolysis of membrane polyphosphoinositides in rat pancreatic islets. Biochem Pharmacol 37:1213–1217
Petit P, Manteghetti M, Puech R, Loubatières-Mariani MM (1987) ATP and phosphate-modified adenine nucleotide analogues: effects on insulin secretion and calcium uptake. Biochem Pharmacol 36:377–380
Qu X, Cooney G, Donnelly R (1997) Short-term metabolic and haemodynamic effects of GR 79236 in normal and fructose-fed rats. Eur J Pharmacol 338:269–276
Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i:785–789
Reaven G, Chang H, Ho H, Jeng CY, Hoffman B (1988) Lowering of plasma glucose in diabetic rats by antilipolytic agents. Am J Physiol 254:E23–E30
Ribes G, Bertrand G, Petit P, Loubatières-Mariani MM (1988) Effects of 2-methylthio ATP on insulin secretion in the dog in vivo. Eur J Pharmacol 155:171–174
Schwabe U, Ebert R, Erbler HC (1975) Adenosine release from fat cells: effect on cyclic AMP levels and hormone actions. Adv Cyclic Nucleotide Res 5:569–583
Squires PE, James RFL, London NJM, Dunne MJ (1994) ATP-induced intracellular Ca2+ signals in isolated human insulin-secreting cells. Pflügers Arch 427:181–183
Stam NJ, Klomp J, Van de Heuvel N, Olijve W (1996) Molecular cloning and characterization of a novel orphan receptor (P2P) expressed in human pancreas that shows high structural homology to the P2U purinoceptor. FEBS Lett 384:260–264
Tang J, Pugh W, Polonsky KS, Zhang H (1996) Preservation of insulin secretory responses to P2 purinoceptor agonists in Zucker diabetic fatty rats. Am J Physiol 270:E504–E512
Taylor WM, Halperin ML (1979) Stimulation of glucose transport in rat adipocytes by insulin, adenosine, nicotinic acid and hydrogen peroxide. Biochem J 178:381–389
Theler JM, Mollard P, Guérineau N, Vacher P, Pralong WF, Schlegel W, Wollheim CB (1992) Video imaging of cytosolic Ca2+ in pancreatic β cells stimulated by glucose, carbachol, and ATP. J Biol Chem 267:18110–18117
Tokuyama Y, Hara M, Jones EMC, Fan Z, Bell GI (1995) Cloning of rat and mouse P2Y purinoceptors. Biochem Biophys Res Commun 211:211–218
Uehara Y, Numabe A, Hirawa N, Kawabata Y, Nagoshi H, Kaneko H, Gomi T, Goto A, Toyo-oka T, Omata M (1995) A new adenosine subtype-1 receptor antagonist, FK-838, attenuates salt-induced hypertension in Dahl salt-sensitive rats. Am J Hypertens 8:1189–1199
UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853
Vannucci SJ, Nishimura H, Satoh S, Cushman SW, Holman GD, Simpson IA (1992) Cell surface accessibility of GLUT4 glucose transporters in insulin-stimulated rat adipose cells. Biochem J 288:325–330
Van Schaick EA, Zuideveld KP, Tukker HE, Langemeijer MW, Ijzerman AP, Danhof M (1998) Metabolic and cardiovascular effects of the adenosine Al receptor agonist N6-(p-sulfophenyl)adenosine in diabetic Zucker rats: influence of the disease on the selectivity of action. J Pharmacol Exp Ther 287:21–30
Vergauwen L, Hespel P, Richter EA (1994) Adenosine receptors mediate synergistic stimulation of glucose uptake and transport by insulin and by contractions in rat skeletal muscle. J Clin Invest 93:974–981
Wang CZ, Namba N, Gonoi T, Inagaki N, Seino S (1996) Cloning and pharmacological characterization of a fourth P2X receptor subtype widely expressed in brain and peripheral tissues including various endocrine tissues. Biochem Biophys Res Commun 220:196–202
Wyatt DA, Edmunds MC, Rubio R, Berne RM, Lasley RD, Mentzer RM Jr (1989) Adenosine stimulates glycolytic flux in isolated perfused rat hearts by Al-adenosine receptors. Am J Physiol 257:H1952–H1957
Xu B, Berkich DA, Crist GH, Lanoue KF (1998) Al adenosine receptor antagonism improves glucose tolerance in Zucker rats. Am J Physiol 274:E271–E279
Yki-Järvinen H (1990) Acute and chronic effects of hyperglycaemia on glucose metabolism. Diabetologia 33:579–585
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Berlin Heidelberg
About this chapter
Cite this chapter
Petit, P., Hillaire-Buys, D., Loubatières-Mariani, M., Chapal, J. (2001). Purinergic Receptors and the Pharmacology of Type 2 Diabetes. In: Abbracchio, M.P., Williams, M. (eds) Purinergic and Pyrimidinergic Signalling II. Handbook of Experimental Pharmacology, vol 151 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56921-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-56921-0_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-67848-9
Online ISBN: 978-3-642-56921-0
eBook Packages: Springer Book Archive